Androgenic alopecia and insulin resistance: Are they really related?

Clinical and Experimental Dermatology

Volumn 34, Issue 6, 2009, Pages 694-697

  Nabaie, L ^a   Kavand, S ^a   Robati, R M ^a   Sarrafi Rad, N ^a   Shahgholi, L ^a   Meshkat Razavi, G ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MALE TYPE ALOPECIA; PRIORITY JOURNAL;

ADULT; ALOPECIA; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHOLESTEROL; FASTING; HAIR FOLLICLE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; TRIGLYCERIDES;

EID: 68249135084     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.03118.x     Document Type: Article

References (17)

1. Matilainen VA, Keinänen-Kiukaanniemi SM. Hormone-induced aberrations in electromagnetic adhesion signaling as a developmental factor of androgenetic alopecia. Med Hypotheses 2002 58 : 261 3.
2. Matilainen VA, Makinen PK, Keinen-Kiukaaniemi SM. Early onset of androgenetic alopecia associated with early severe coronary heart disease: a population-based, case-control study. J Cardiovasc Risk 2001 8 : 147 51.
3. Pinkney JH, Stehouwer CD, Coppack SW, Yudkin JS. Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes 1997 46 : 9 13.
4. Duskova M, Cermakova I, Hill M, Vankova M. What may be the markers of the male equivalent of polycystic ovary syndrome? Physiol Res 2004 53 : 287 94.
5. Matilainen V, Koskela P, Keinanen S. Early androgenetic alopecia as a marker of insulin resistance. Lancet 2000 356 : 1165 6.
6. Norwood OT. Male pattern baldness: classification and incidence. South Med J 1975 68 : 1359 65.
7. Grundy SM, Brewer HB Jr., Cleeman JI et al. Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004 109 : 433 8.
8. Severi G, Sinclair R, Hopper JL et al. Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors. Br J Dermatol 2003 149 : 1207 13.
9. Klemp P, Peters K, Hansted B. Subcutaneous bood flow in early male pattern baldness. J Invest Dermatol 1989 92 : 725 6.
10. Goldman BE, Fisher DM, Ringler SL. Transcutaneous PO2 of the scalp in male pattern baldness: a new piece to the puzzle. Plast Reconstr Surg 1996 97 : 1109 17.
11. Yip J, Mattock MB, Morocutti A et al. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 1993 342 : 883 7.
12. Ellis JA, Stebbing M, Harrap SB. Insulin gene polymorphism and premature male pattern baldness in the general population. Clin Sci (Lond) 1999 96 : 659 62.
13. LinksHirsso P, Laakso M, Matilainen V et al. Association of insulin resistance linked diseases and hair loss in elderly men. Finnish population-based study. Cent Eur J Public Health 2006 14 : 78 81.
14. Platz EA, Pollak MN, Willett WC, Giovannucci E. Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3. J Am Acad Dermatol 2000 42 : 1003 7. (Pubitemid 30368668)
15. Matilainen V, Laakso M, Hirsso P et al. Hair loss, insulin resistance, and heredity in middle-aged women. A population-based study. J Cardiovasc Risk 2003 10 : 227 31.
16. Ekmekci TR, Ucak S, Basat O et al. The presence of insulin resistance and comparison of various insulin sensivity indices in women with androgenetic alopecia. Eur J Dermatol 2007 17 : 21 5.
17. Giltay EJ, Toorians AW, Sarabdjitsingh AR et al. Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transsexuals. J Endocrinol 2004 180 : 107 12.